Obesity Management in Female Adolescents
Clinical Endocrinology · 21.04.2025
DOI: 10.1111/cen.15238 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Endocrinology, online erschienen am 21.04.2025. Verfasst von Lauryn P Roth und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric and Adolescent Gynecology, University of Colorado Anschutz, Aurora, Colorado, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Background
Global childhood obesity continues to rise, particularly in adolescent females. The underlying cause of this change in prevalence is multifactorial with a complex interplay of genetic, socioeconomic and environmental influences. In this review, we aim to emphasize the multiple options available for assisting an adolescent female to improve their overall health and longevity.
Design
Experts from each of their respective fields reviewed the current literature regarding the management of obesity in female adolescents.
Results
Lifestyle changes, including decreases in overall calorie consumption and simple carbohydrates as well as increases in activity/exercise have been the mainstay of obesity therapy due to their effects on decreasing insulin resistance and associated metabolic disease, as well as weight loss. However, the combination of provider encouraged weight loss and societal obesity stigma leads to an increased risk for disordered eating. The high prevalence of mental health and sleep disorders in female youth with obesity are recent findings, as is the importance in treating these conditions for improved quality of life as well as success with lifestyle changes. The American Academy of Pediatrics' 2023 obesity guidelines are the first across the globe to recommend early adjunctive use of weight loss medications for obesity. These recommendations correspond with the development and increasing availability of new combinations of existing mediations as well as the glucagon like peptide‐1 receptor agonist class of medications. Youth with a body mass index in excess of 35−40 kg/m 2 , can now undergo bariatric surgery in many countries, with very encouraging short‐ and medium‐term success.
Conclusion
There are now many approaches to consider when treating an adolescent female for obesity or associated metabolic disease, and customized approaches may be needed for optimal success at the individual patient level.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric and Adolescent Gynecology, University of Colorado Anschutz, Aurora, Colorado, USA.
- Pediatric Endocrinology, University of Florida Gainsville, Gainsville, Florida, USA.
- Lifestyle Medicine, Children's Hospital Colorado, Aurora, Colorado, USA.
- Barbara Davis Center, University of Colorado Anschutz, Aurora, Colorado, USA.
- Pediatric Endocrinology, Harvard/Mass General, Boston, Massachusetts, USA.
- Department of Nutrition, Texas A&M University, College Station, Texas, USA.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Roth, L. P., Bernier, A., Gulley, L., Lohse, K., Whooten, R., Allen, L., Brink, H. V., Sfeir, J., Simon, S., Finn, E., & Cree, M. G. (2025). Obesity Management in Female Adolescents. Clinical Endocrinology. https://doi.org/10.1111/cen.15238
Vancouver
Roth LP, Bernier A, Gulley L, Lohse K, Whooten R, Allen L, et al. Obesity Management in Female Adolescents. Clinical Endocrinology. 2025. doi:10.1111/cen.15238
BibTeX
@article{Roth2025,
author = {Roth, Lauryn P and Bernier, Angelina and Gulley, Lauren and Lohse, Kristen and Whooten, Rachel and Allen, Leora and Brink, Heidi Vanden and Sfeir, Joelle and Simon, Stacey and Finn, Erin and Cree, Melanie G},
title = {Obesity Management in Female Adolescents},
journal = {Clinical Endocrinology},
year = {2025},
doi = {10.1111/cen.15238}
}
EUVIMED